Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial.

Journal article

Fidler S. et al, (2020), Lancet (London, England), 395, 888 - 898

Novel Nested Peptide Epitopes Recognized by CD4+ T Cells Induced by HIV-1 Conserved-Region Vaccines.

Journal article

Borthwick N. et al, (2020), Vaccines, 8

Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80.

Journal article

Mothe B. et al, (2020), EClinicalMedicine, 18

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02).

Journal article

Mothe B. et al, (2020), Frontiers in Immunology, 11

In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial.

Journal article

Rosás-Umbert M. et al, (2020), Frontiers in immunology, 11

Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials

Journal article

Hanke T., (2019), Expert Review of Vaccines, 1 - 13

Development of Pan-filovirus T cell vaccines against Ebola and Marburg virus challenges

Conference paper

Qiu X. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1664 - 1664

Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1.

Journal article

Wee EG. et al, (2019), Mol Ther Methods Clin Dev, 14, 148 - 160

Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice.

Journal article

Kilpeläinen A. et al, (2019), Vaccines (Basel), 7

Lessons from the Research in Viral Eradication of Reservoirs (RIVER) study: Impact of a therapeutic vaccine targeting conserved HIV epitopes on T cell function in treated primary infection

Conference paper

Kopycinski J. et al, (2019), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 22, 20 - 21

MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice

Journal article

Broset E. et al, (2019), Molecular Therapy - Methods and Clinical Development, 13, 253 - 264

Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study).

Journal article

Mothe B. et al, (2019), EClinicalMedicine, 11, 65 - 80

No evidence of neuroaxonal injury following latency reversal with vorinostat and HIV-1 specific vaccination in the RIVER trial

Conference paper

Alagaratnam J. et al, (2019), HIV MEDICINE, 20, 25 - 25

The impact of vorinostat and therapeutic vaccine on gut HIV DNA: the RIVER gut study

Conference paper

Thornhill J. et al, (2019), HIV MEDICINE, 20, 7 - 7

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA

Journal article

Moyo N. et al, (2019), Molecular Therapy - Methods and Clinical Development, 12, 32 - 46

Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.

Journal article

Zou C. et al, (2019), J Virol

Construction and Characterization of Recombinant MTBVAC. HIV, a New Live Attenuated Vaccine Against HIV and Tuberculosis

Conference paper

Saubi N. et al, (2018), AIDS RESEARCH AND HUMAN RETROVIRUSES, 34, 314 - 314

Control of HIV-1 by CD8+T Cells Specific for Epitopes of Conserved Mosaic Vaccine Immunogens

Conference paper

Murakoshi H. et al, (2018), AIDS RESEARCH AND HUMAN RETROVIRUSES, 34, 172 - 172

Recombinant BCG: tHIVconsvX Prime-ChAdOx: tHIVconsvX Boost Regimen Was Safe, Stable and Elicited Specific HIV-1 T-cell Immune Responses in BALB/C Mice

Conference paper

Kilpelainen A. et al, (2018), AIDS RESEARCH AND HUMAN RETROVIRUSES, 34, 327 - 327

Identification of novel HIV-1-derived HLA-E-binding peptides.

Journal article

Hannoun Z. et al, (2018), Immunol Lett

Load More